Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.
作者信息
Sahu Kamal Kant, Siddiqui Ahmad Daniyal, Cerny Jan
机构信息
Division of Hematology and Oncology, Department of Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Division of Hematology and Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA, USA.
出版信息
Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.
Abstract
摘要
相似文献
1
Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.管理新冠病毒感染的镰状细胞病患者：汇聚我们集体经验的必要性。
Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.
2
COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.镰状细胞病患者的新型冠状病毒肺炎——来自英国一家三级医院的病例系列
Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.
3
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
4
COVID-19 and sickle cell disease.新型冠状病毒肺炎与镰状细胞病
Haematologica. 2020 Nov 1;105(11):2501-2504. doi: 10.3324/haematol.2020.255398.
5
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.减轻新冠疫情对非洲国家镰状细胞病服务的影响。
Lancet Haematol. 2020 Jun;7(6):e430-e432. doi: 10.1016/S2352-3026(20)30122-8. Epub 2020 Apr 23.
6
Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.撒哈拉以南非洲地区镰状细胞病患者感染新冠病毒的易感性。
Hematology. 2020 Dec;25(1):280-282. doi: 10.1080/16078454.2020.1790842.
7
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.新型冠状病毒肺炎感染对24例镰状细胞病患者的影响。美国密歇根州底特律市一家中心的城市经验。
Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28.
8
Rare Anaemias, Sickle-Cell Disease and COVID-19.罕见贫血、镰状细胞病与 COVID-19
Acta Biomed. 2020 May 11;91(2):216-217. doi: 10.23750/abm.v91i2.9532.
9
A hospital-based COVID-19 abortion case in the early phase of the pandemic.医院在大流行早期的 COVID-19 流产病例。
Contraception. 2020 Aug;102(2):137-138. doi: 10.1016/j.contraception.2020.05.005. Epub 2020 May 19.
10
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).2019新型冠状病毒病（COVID-19）所致镰状细胞病的血管闭塞性危机和急性胸综合征
Am J Hematol. 2020 Jun;95(6):725-726. doi: 10.1002/ajh.25821. Epub 2020 Apr 21.
引用本文的文献
1
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.2019冠状病毒病感染对镰状细胞病患者的影响：一项综合综述。
Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.
2
Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.1型干扰素基因特征对镰状细胞病中COVID-19严重程度和慢性炎症的潜在影响。
Front Med (Lausanne). 2021 Jul 22;8:679030. doi: 10.3389/fmed.2021.679030. eCollection 2021.
3
Mild anemia as a single independent predictor of mortality in patients with COVID-19.轻度贫血作为COVID-19患者死亡率的单一独立预测因素。
EJHaem. 2021 May 6;2(3):319-326. doi: 10.1002/jha2.167. eCollection 2021 Aug.
4
Presentation, management, and outcomes of COVID-19 in patients with sickle cell disease.镰状细胞病患者中新型冠状病毒肺炎的临床表现、治疗及预后
EJHaem. 2021 Feb;2(1):124-127. doi: 10.1002/jha2.162. Epub 2021 Jan 12.
5
COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange.一名患有镰状细胞病的儿科患者因 COVID-19 肺炎需要进行红细胞置换。
Clin Case Rep. 2021 Jan 12;9(3):1367-1370. doi: 10.1002/ccr3.3774. eCollection 2021 Mar.
6
Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome.镰状细胞病并发症（急性胸部综合征除外）的管理
J Blood Med. 2021 Feb 25;12:101-114. doi: 10.2147/JBM.S291394. eCollection 2021.
7
Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants.两名婴儿同时被诊断出患有严重的SARS-CoV-2感染和镰状细胞病。
Blood Transfus. 2021 Mar;19(2):120-123. doi: 10.2450/2021.0430-20. Epub 2021 Feb 3.
8
Current Perspectives of convalescent plasma therapy in COVID-19.COVID-19 恢复期血浆疗法的现状。
Acta Biomed. 2020 Nov 10;91(4):e2020175. doi: 10.23750/abm.v91i4.10681.
9
COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.镰状细胞病患者中的新冠病毒疾病：来自美国俄亥俄州的单中心经验
J Med Virol. 2021 May;93(5):2591-2594. doi: 10.1002/jmv.26816. Epub 2021 Feb 1.
10
Hemoglobinopathy and pediatrics in the time of COVID-19.COVID-19 时代的血红蛋白病与儿科学
Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):87-100. doi: 10.1016/j.htct.2020.11.002. Epub 2020 Dec 2.
本文引用的文献
1
Cancer treatment during COVID-19 pandemic.在 COVID-19 大流行期间的癌症治疗。
Med Oncol. 2020 May 29;37(7):58. doi: 10.1007/s12032-020-01382-w.
2
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
3
COVID-19 pandemic and impact on hematopoietic stem cell transplantation.2019冠状病毒病大流行及其对造血干细胞移植的影响。
Bone Marrow Transplant. 2020 Nov;55(11):2193-2195. doi: 10.1038/s41409-020-0913-6. Epub 2020 May 4.
4
Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome.托珠单抗治疗一名患有镰状细胞病和急性胸部综合征的儿童重症 COVID-19 后病情显著改善。
Am J Hematol. 2020 Aug;95(8):E192-E194. doi: 10.1002/ajh.25855. Epub 2020 May 16.
5
From Hematologist's desk: The effect of COVID-19 on the blood system.血液科医生手记：新型冠状病毒肺炎对血液系统的影响
Am J Hematol. 2020 Aug;95(8):E213-E215. doi: 10.1002/ajh.25849. Epub 2020 May 8.
6
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians.造血细胞移植背景下面对新型冠状病毒肺炎：移植医生面临的新挑战。
Blood Cells Mol Dis. 2020 Jul;83:102439. doi: 10.1016/j.bcmd.2020.102439. Epub 2020 Apr 11.
7
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.减轻新冠疫情对非洲国家镰状细胞病服务的影响。
Lancet Haematol. 2020 Jun;7(6):e430-e432. doi: 10.1016/S2352-3026(20)30122-8. Epub 2020 Apr 23.
8
Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.在 COVID-19 大流行期间，保护患有遗传性贫血的脆弱患者免于不必要的死亡。
Br J Haematol. 2020 May;189(4):635-639. doi: 10.1111/bjh.16687. Epub 2020 May 10.
9
COVID-19 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒肺炎感染
Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.
10
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.一名镰状细胞病患者出现快速进展且严重的新冠病毒肺炎并伴有严重急性胸部综合征，使用托珠单抗成功治疗。
Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.
Zotero 插件